Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute . To determine whe

Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas M. D. Anderson Cancer Center. The findings, presented in a poste

Women with breast cancer should be given high doses of vitamin D because a majority of them are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures, according to scientists at the University of Rochester Medical Center. In a study of

The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio. The awards will be given by the American Association for Cancer Research, which together with the Cancer Therapy and Research Center at

New studies on the early detection, evaluation and treatment of breast cancer were released today in advance of the 2009 Breast Cancer Symposium. The symposium is being held October 8-10, 2009, at the San Francisco Marriott. Four major studies were highlighted today in a presscast (press briefing

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, has many reasons to celebrate this October as it recognizes Breast Cancer Awareness Month. The NIEHS Sister Study began recruiting women for this landmark study during Breast Cancer Awareness

Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-

Breast cancer therapy that's customized for each patient's personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Cancer Institute (RPCI). A team led by Petr Starostik, MD, chief of RPCI's Clinical Molecular Diagnostics lab, is u

According to new research from the American College of Surgeons (ACoS), two-thirds of women (66 percent) did not know about accreditation of breast care centers, what it means, and why it is important. However, after providing women who were surveyed with an overview of the meaning of accreditation,

The University of California is launching an unprecedented statewide collaboration for breast cancer patients with the goal of revolutionizing the course of their care by designing and testing new approaches to research, technology and health care delivery. Named the ATHENA Breast Health Network,